SRSilvia Reyes-Maya

Silvia Reyes-Maya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Silvia Reyes-Maya has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Amanda Gayosso-Vázquez

    Universidad Nacional Autónoma de México. Facultad de Medicina Veterinaria y Zootecnia. Departamento de Genética y Bioestadística. Laboratorio de Genética Molecular. Ciudad de México, México

    1 shared publication
  • Carlos G. Gutierrez

    Departamento de Reproducción, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autonoma de Mexico, Mexico City 04510, Mexico

    1 shared publication
  • Israel Muñoz-Velasco

    Universidad Nacional Autónoma de México. Facultad de Ciencias. Departamento de Biología Celular. Ciudad de México, México

    1 shared publication
  • María Luisa Escobar

    Universidad Nacional Autónoma de México. Facultad de Ciencias. Departamento de Biología Celular. Ciudad de México, México

    1 shared publication
  • Olga Margarita Echeverría

    Universidad Nacional Autónoma de México. Facultad de Ciencias. Departamento de Biología Celular. Ciudad de México, México

    1 shared publication
  • Pablo Pintor Ríos

    Universidad Nacional Autónoma de México. Facultad de Medicina Veterinaria y Zootecnia. Departamento de Genética y Bioestadística. Laboratorio de Genética Molecular. Ciudad de México, México

    1 shared publication

Latest Publications

  • Open Access

    DNA vaccine targeting GnRH-receptor reduces testosterone and induces testicular atrophy in mice

    by Silvia Reyes-Maya, Amanda Gayosso-Vázquez, Vianey Ramírez-Andoney, Pablo Pintor Ríos, María Luisa Escobar, Israel Muñoz-Velasco, Olga Margarita Echeverría, Carlos G. Gutiérrez, Rogelio Alejandro Alonso-Morales

    Reproductive control of invasive, feral, and domesticated animals is an urgent public health issue. Immunological vaccines are employed as an emerging strategy to target different components of the reproductive system, to achieve immunocastration. Successful use of immunogens against parts of the oocyte, spermatozoon, gonadotropin-releasing hormone (GnRH), and luteinizing hormone receptor (LHr) has been reported. In this work, a recombinant DNA vaccine was prepared (P2GnRHrP30) by the fusion of the first extracellular domain of the canine GnRH receptor (GNRHr) gene to the P2 and P30 tetanus toxoid epitopes. This construction was cloned in the pCI-NEO mammalian expression vector and evaluated as an immunocontraception DNA vaccine in male mice. The developed vaccine was demonstrated to be safe, and capable of reducing serum testosterone levels and causing testicular atrophy. Our work indicates that the first extracellular domain of the GnRHr gene may act as an immune target for reproductive control and potentially be used as a non-surgical sterilization procedure in mammals.